Relief Therapeutics Holding AG entered into a definitive agreement for the private placement of up to 1,500,000 common shares at an issue price of CHF 3.330 per share for gross proceeds of CHF 4,995,000 along with warrants on June 16, 2023. The warrants will have an exercise price of CHF 3.40 per share, will be immediately exercisable upon issuance, and will expire five years from the date of issuance. The warrants are purchasable for up to 1,500,000 ordinary shares at a purchase price of CHF 3.330 per share.

The private placement is expected to close on or about June 21, 2023, subject to the satisfaction of customary closing conditions. The common shares and, upon exercise, the shares underlying the warrants, will be traded on the SIX Swiss Exchange and rank pari passu with the company's common shares, and will be delivered from the company’s treasury shares previously issued out of its authorized share capital under exclusion of the existing shareholders’ pre-emptive rights.